News
For Facility Assessments, FDA Recommends Alternative Tools
The US FDA has gone on to release a draft guidance that outlines its approach to utilising alternative methods so as to evaluate drug manufacturing facilities that are included in pending marketing applications.
For instance, the applications include new drug...
News
Swedish Stakeholders Seek Alterations In EU Pharma Reforms
The Swedish government this summer has gone on to provide an opportunity for more than 120 stakeholders so as to share their viewpoints on the new EU pharmaceutical package that was put forward by the European Commission in April...
News
Factors That Make Pharma Packaging Innovations A Reality
Companies within the pharma industry are starting to take notice of several exciting innovations. Be it artificial intelligence, blockchain, or automation, all have the ability to enhance the efficiency of the pharmaceutical packaging process and improve the tracking of...
News
The Exciting State of The Pharmaceutical Cold Chain Arena
In the past decade, there has been a rapid evolution in the industry practices related to delivering temperature-sensitive pharmaceuticals. During the 2000s, a pharmaceutical cold chain interest group emerged among industry experts with the aim to promote and come...
News
Fibre-Based Packaging: Way To A Sustainable Pharma Future?
It is impossible to ignore the worldwide push for sustainability. It indeed plays an increasingly significant role in shaping our daily lives, influencing everything from the vehicles we use to the food we consume. While prioritising the health of patients...
News
Husky Grabs The Innovation In Bioplastics Award For 2023
Husky Technologies has been announced as the recipient of PLASTICS' 2023 Innovation in Bioplastics Award by the Plastics Industry Association- PLASTICS. The announcement on October 4 was made during PLASTICS' 8th annual online event called #BioplasticsWeek, which strives to...
Drug Research
Gritgen Therapeutics Launches Commercial GMP Facility in China
Gritgen Therapeutics Co., a biotechnology company focused on gene therapy products, reported the successful validation and launch of operations at its commercial GMP facility in Suzhou China for the production of Gritgen's phase III clinical and commercial product for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read